home / stock / akus / akus news


AKUS News and Press, Akouos Inc.

Stock Information

Company Name: Akouos Inc.
Stock Symbol: AKUS
Market: NASDAQ
Website: akouos.com

Menu

AKUS AKUS Quote AKUS Short AKUS News AKUS Articles AKUS Message Board
Get AKUS Alerts

News, Short Squeeze, Breakout and More Instantly...

AKUS - Lilly and Akouos Announce Expiration of Akouos Tender Offer

Lilly and Akouos Announce Expiration of Akouos Tender Offer PR Newswire INDIANAPOLIS and BOSTON , Nov. 30, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all o...

AKUS - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LMST, AIMC, ABMD, AKUS

NEW YORK, NY / ACCESSWIRE / November 18, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Limestone Bancorp, Inc. (NASDAQ:...

AKUS - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OFIX, AKUS, PEBO

NEW YORK, NY / ACCESSWIRE / November 17, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Orthofix Medical Inc. (NASDAQ:OF...

AKUS - Akouos GAAP EPS of -$0.54 beats by $0.11

Akouos press release ( NASDAQ: AKUS ): Q3 GAAP EPS of -$0.54 beats by $0.11 . Cash, cash equivalents, and marketable securities were $169.3 million For further details see: Akouos GAAP EPS of -$0.54 beats by $0.11

AKUS - Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights

-Received clearance from FDA for the AK-OTOF IND application to initiate a Phase 1/2, first in human, pediatric clinical trial -Continued progress toward planned IND submission for AK-antiVEGF in 2023 -Announced on October 18 definitive agreement for Eli Lilly and Compan...

AKUS - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOTZ, BTRS, KNBE, AKUS

NEW YORK, NY / ACCESSWIRE / November 13, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CarLotz, Inc. (NASDAQ:LOTZ)'s ...

AKUS - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FBMS, LFG, AKUS

N EW YORK, NY / ACCESSWIRE / November 4, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: The First Bancshares, Inc. (NASDA...

AKUS - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKUS, AIMC, PEBO, LMST

NEW YORK, NY / ACCESSWIRE / November 3, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Akouos, Inc. (NASDAQ: AKUS)'s s...

AKUS - Axsome: Ramifications Of Recent Biotech Deals

Summary The macroeconomic factors create a highly favorable mergers and acquisition environment. Several interesting deals are being executed this month. As it's a strong buyers' market, you're likely to see more buyouts going toward year-end and next year. Axsome is an ideal ...

AKUS - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, LFG, AKUS, CLR

NEW YORK, NY / ACCESSWIRE / October 27, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: BTRS Holdings Inc. (NASDAQ:BTRS)'...

Next 10